Search
Aveanna Healthcare Holdings Inc
AVAHAdd to Watchlist
7.915USD
+0.125+1.60%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
1.65BMarket Cap
6.22P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Aveanna Healthcare Holdings Inc is 8.00, ranking 30 out of 76 in the Healthcare Providers & Services industry. The average price target is 10.00, with a high of 13.00 and a low of 9.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
10.278
Target Price
+31.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Aveanna Healthcare Holdings Inc
AVAH
11
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Aveanna Healthcare Holdings Inc's expected revenue for the next quarter?
Aveanna Healthcare Holdings Inc's expected revenue is 635.48M.
What is Aveanna Healthcare Holdings Inc's price target?
Analysts forecast that Aveanna Healthcare Holdings Inc's price target is USD 10.00, with the highest forecast at USD 13.00 and the lowest forecast at USD 9.00.
How have Aveanna Healthcare Holdings IncAVAH's recent earnings per share performed?
The market expectation was USD 0.19, while Aveanna Healthcare Holdings IncAVAH's earnings per share (EPS) for the previous quarter was USD 0.85. EPS for the next quarter is expected at USD 0.16.
What is the analyst rating for Aveanna Healthcare Holdings Inc?
Based on the ratings of Aveanna Healthcare Holdings Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
